Eclipse Life Sciences is a Duke University spinout Ophthalmic Research and Development Company, whose mission is to develop a portfolio of predominantly back-of-the-eye investigational drug products to address clinical unmet needs. Eclipse aims to develop impactful drug products, both first-in-class and best-in-class, that are Phase 3 clinical trial-ready for acquisition by commercial-stage pharmaceutical companies.
| Website | https://www.globenewswire.com/news-release/2024/08/12/2928305/0/en/Eclipse-Life-Sciences-Initiates-Phase-2-Study-for-Novel-Ophthalmology-Steroid-Implant-for-Diabetic-Macular-Edema-DME.html |
| Revenue | $96.9 million |
| Employees | 5 (1 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Eclipse Life Sciences employee's phone or email?
Eclipse Life Sciences Questions
The Eclipse Life Sciences annual revenue was $96.9 million in 2026.
1 people are employed at Eclipse Life Sciences.
Top Eclipse Life Sciences Employees
G2Crowd Trusted
300K+
Plugin Users
